UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.546

Sortiert nach

Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity

British journal of pharmacology, 2021-12, Vol.178 (23), p.4708-4725

2021

Link zum Volltext

Verfügbarkeit prüfen

Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe

European journal of human genetics : EJHG, 2020-01, Vol.28 (1), p.88-94

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6

Pharmacogenomics, 2017-05, Vol.18 (7), p.701-739

2017

Link zum Volltext

Verfügbarkeit prüfen

Antimalarial activity of primaquine operates via a two-step biochemical relay

Nature communications, 2019-07, Vol.10 (1), p.3226-9, Article 3226

2019

Link zum Volltext

Verfügbarkeit prüfen

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

European journal of human genetics : EJHG, 2024-03, Vol.32 (3), p.278-285

2024

Link zum Volltext

Verfügbarkeit prüfen

Autoimmmune hepatitis

Cellular & molecular immunology, 2022-02, Vol.19 (2), p.158-176

2022

Link zum Volltext

Verfügbarkeit prüfen

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

European journal of human genetics : EJHG, 2022-10, Vol.30 (10), p.1114-1120

2022

Link zum Volltext

Verfügbarkeit prüfen

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

European journal of human genetics : EJHG, 2022-10, Vol.30 (10), p.1105-1113

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP2D6 10 and 41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine

Journal of clinical pharmacology, 2024-05, Vol.64 (5), p.601-608

2024

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta‐analysis

Pharmacotherapy, 2020-07, Vol.40 (7), p.632-647

2020

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic insights on nsSNPs on binding site of renin and cytochrome P450 proteins: A computational perceptual study for pharmacogenomics evaluation

Journal of cellular biochemistry, 2021-10, Vol.122 (10), p.1460-1474

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients

Breast cancer research : BCR, 2017-11, Vol.19 (1), p.125-125, Article 125

2017

Link zum Volltext

Verfügbarkeit prüfen

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

European journal of human genetics : EJHG, 2023-12, Vol.31 (12), p.1364-1370

2023

Link zum Volltext

Verfügbarkeit prüfen

Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition

Journal of clinical pharmacology, 2022-01, Vol.62 (1), p.76-86

2022

Link zum Volltext

Verfügbarkeit prüfen

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data

Science translational medicine, 2021-07, Vol.13 (603)

2021

Link zum Volltext

Verfügbarkeit prüfen

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply

The Lancet (British edition), 2023-06, Vol.401 (10391), p.1851-1852

2023

Link zum Volltext

Verfügbarkeit prüfen

Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D617 and CYP2D629, When Compared with Normal Metabolizers

Journal of clinical pharmacology, 2024-05, Vol.64 (5), p.578-589

2024

Link zum Volltext

Verfügbarkeit prüfen

Using population pharmacokinetic analyses of drugs metabolized by CYP2D6 to study the genotype–phenotype translation

Basic & clinical pharmacology & toxicology, 2023-08, Vol.133 (2), p.113-123

Frederiksen, Trine

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

The pharmacogenomics journal, 2013-02, Vol.13 (1), p.1-11

2013

Link zum Volltext

Verfügbarkeit prüfen

Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016

Drug metabolism and disposition, 2018-06, Vol.46 (6), p.835-845

2018

Link zum Volltext

Verfügbarkeit prüfen

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population

The Journal of infectious diseases, 2019-10, Vol.220 (11), p.1761-1770

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of CYP2D6 genotype on duloxetine serum concentration

Basic & clinical pharmacology & toxicology, 2024-01, Vol.134 (1), p.186-192

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction: National Prociency Testing Result of CYP2D610 Genotyping for Adjuvant Tamoxifen Therapy in China

PloS one, 2016-12, Vol.11 (12), p.e0167740-e0167740

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese

Clinical and experimental pharmacology & physiology, 2020-10, Vol.47 (10), p.1659-1663

2020

Link zum Volltext

Verfügbarkeit prüfen

Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing

Pharmacogenomics, 2017-05, Vol.18 (7), p.673-685

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.546

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.503)
Mit Volltextzugriff
(1.252)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.398)
Life Sciences & Biomedicine
(1.305)
Humans
(1.078)
Cytochrome P450
(1.061)
Cyp2d6 Protein
(1.017)
Pharmacology & Pharmacy
(704)
Cytochrome P-450 Cyp2d6 - Genetics
(546)
Metabolism
(518)
Cytochrome P-450 Cyp2d6 - Metabolism
(422)
Enzymes
(421)
Female
(382)
Male
(372)
Cyp2d6
(353)
Cytochrome
(330)
Metabolites
(309)
Pharmacogenetics
(302)
Pharmacokinetics
(302)
Genotype
(266)
Adult
(255)
Biological And Medical Sciences
(250)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity

Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe

Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6

Antimalarial activity of primaquine operates via a two-step biochemical relay

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

Autoimmmune hepatitis

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

Effects of CYP2D6 10 and 41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine

CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta‐analysis

Mechanistic insights on nsSNPs on binding site of renin and cytochrome P450 proteins: A computational perceptual study for pharmacogenomics evaluation

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply

Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D617 and CYP2D629, When Compared with Normal Metabolizers

Using population pharmacokinetic analyses of drugs metabolized by CYP2D6 to study the genotype–phenotype translation

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population

Effect of CYP2D6 genotype on duloxetine serum concentration

Correction: National Prociency Testing Result of CYP2D610 Genotyping for Adjuvant Tamoxifen Therapy in China

Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese

Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing

Suchergebnisse filtern